GJA1 and diabetic retinopathy: A recent study demonstrated that retinal vascular cell treated with danegaptide preserved Cx43 GJ intercellular communication, decreased cell death, and reduced cell monolayer permeability, in an in vitro model of diabetic retinopathy [32].